ArticleHepatology international2024
Comments on: Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis.
Yan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.